As with individuals with NAFLD, Tcf7l2 expression was markedly decreased to below-normal levels in the liver of C57BL/6N mice fed an HFD or HCD for 22 weeks (Fig. 2a,b). Here, TCF7L2 is linked to metabolic dysfunction-associated steatotic liver disease.